Irvine, CA
AIBIOS has designed and developed a series of novel small molecules which modulate both the innate (macrophages) and adaptive immune system to treat therapeutic indications of Gastroenterology, Respiratory, and Neurological diseases.
aibios.comThese are collections AIBIOS is a part of. Click on the collection name to view similar companies.
Seed
500,000,000 JPY
Seed
350,000,000 JPY
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on AIBIOS.